Cargando…
71. Use of Intravenous Immunoglobulin Therapy Reduces Progression to Mechanical Ventilation in COVID-19 Patients with Moderate to Severe Hypoxia
BACKGROUND: The majority of COVID-19 morbidity and mortality occurs in patients who progress to mechanical ventilation. Therefore, therapeutic interventions targeting the mitigation of this complication would markedly improve outcomes and reduce healthcare utilization. METHODS: Patients with COVID-1...
Autores principales: | Sakoulas, George, Geriak, Matthew, Kullar, Ravina, Greenwood, Kris, Habib, Mackenzie, Vyas, Anuja, Ghafourian, Mitra, Dintyala, Venkata Naga Kiran, Haddad, Fadi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778308/ http://dx.doi.org/10.1093/ofid/ofaa439.381 |
Ejemplares similares
-
Intravenous Immunoglobulin Plus Methylprednisolone Mitigate Respiratory Morbidity in Coronavirus Disease 2019
por: Sakoulas, George, et al.
Publicado: (2020) -
Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia
por: Geriak, Matthew, et al.
Publicado: (2021) -
Case Series of Successful Intravenous Immunoglobulin (IVIG) Treatment in 4 Pregnant Patients with Severe COVID-19-Induced Hypoxia
por: Geriak, Matthew, et al.
Publicado: (2022) -
Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Geriak, Matthew, et al.
Publicado: (2019) -
Abrogation of neutrophil inflammatory pathways and potential reduction of neutrophil-related factors in COVID-19 by intravenous immunoglobulin
por: Masso-Silva, Jorge Adrian, et al.
Publicado: (2022)